Major insurance change hits users of Zepbound for weight loss
Millions of patients using GLP-1 drugs for weight loss could see costs skyrocket.
Pharmacy
PBM rules dropped from Senate passed version of Trump's Bill
The policy would have prevented PBMs from having their compensation linked to the list prices of medications.
Mark Ratner joins AAM to lead Government Relations
Ratner will lead AAM’s government relations team across federal and state relations, advocacy, and alliances.
Kroger Health expands relationship to enhance patient care and access
The agreement with Centene will include pharmacist-led initiatives such as medication optimization, which can lead to improved quality of care and outcomes.
Big pharma prepares for next patent cliff as blockbuster drugs revenue losses loom, says GlobalData
According to GlobalData’s latest report, “Blockbuster Drugs on Patent Cliffs,” there is set to be a smaller proportion of global drug sales which will have patent protection in 2030, a sharp drop compared to previous years.
WeightWatchers and Novo Nordisk expand partnership
WeightWatchers clinic members can access FDAapproved Wegovy for $299 in July.
PCMA and NACDS respond to PBM reform legislation in Illinois
The legislation includes banning spread pricing and requiring PBMs to pass 100% of manufacturer rebates to health plans or patients.
Senate narrowly passes Trump budget deal with deep healthcare cuts
The CBO estimates the legislation, which now heads to the House, would result in 11.8 million Americans losing health insurance by 2034.
Moderna’s flu vaccine shows positive late-stage trial results, could lead to combination COVID shot
"An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination vaccines."
NCPA laments SCOTUS decision to punt on Oklahoma PBM reform
Court’s inaction creates confusion in the states.
PCMA supports FTC/DOJ listening session on Big Pharma patent abuse
PCMA voiced support for a series of legislative and regulatory reforms.
Hikma to spend $1 billion to expand generic drug manufacturing and R&D in the U.S.
The new investment phase builds on over 34 years years of serving the needs of U.S. patients and healthcare providers.
Revolutionizing adherence: Clinical trials go digital with enhanced Key-Pak
Key-Pak with Med-Con integration delivers cost-effective digital monitoring—boosting compliance, improving data quality, and empowering study teams.
Hawai'i Pharmacists Association and APhA celebrate passage of landmark legislation
This legislation mandates that beginning July 1, 2026, private and public health plans in Hawai'i must reimburse licensed pharmacists for covered health services of contracted pharmacists when those services are delivered within pharmacists' scope of practice.
CHPA welcomes new board members at June meeting
“Each brings a wealth of leadership experience, strategic insight, and a deep commitment to consumer health and wellness.”
NACDS urges Congress act as key PBM reforms are stripped from budget bill
The removed provisions—a ban on PBM spread pricing in Medicaid managed care and a reimbursement rate floor—were included in both the House bill and the Senate Finance Committee's version.